A clinical study to evaluate efficacy and safety of Appetol syrup in children suffering from non-specific anorexia - NI

ARJUN HEALTHCARE0 个研究点目标入组 50 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1 The informed consent document must be read signed and dated by subjects legally authorized representative before conducting any study procedures or examination
•2 Males and females between 5 to 9 years of age
•3.Subjects suffering from non specific anorexia
•4.Subjects having normal vital parameters

•1 Children with SNAQ score less than or equal to 14
•2 Children with chronic illnesses congenital abnormalities
•3 Subject who is on other appetite stimulants sedatives narcotics and steroidal drugs
•4 Subjects who have received treatment another investigational agent within last thirty days from Screening Visit
•5 Subjects who have received chemotherapy or radiation therapy within the past 5 years
•6 Subjects on systemic antibiotics or systemic therapy with cytotoxic drugs
•7 Subjects having metabolic and or endocrine disorders
•8 Subjects with any type of GI tract disorder including malabsorption syndrome etc
•9 Subjects with liver and renal disorders
•10 Subjects with known immunological, hematologic disorders or malignancy
•11 Subjects having known neurological or psychiatric pathologies
•12 Subjects with history of raised levels of cortisol abnormalities of thyroid hormone growth hormone and insulin secretion
•13 Subject or LAR refuse to sign informed consent form
•14 Subjects having a known hypersensitivity to Appetol Syrup and any of the ingredients of Appetol Syrup

发起方